MJNA lower highs moved to a higher high. Something I just noticed about MJNA. It's been posting lower highs with OTC:MJNA each consecutive run, but the most recent run last year to .22 was a higher high. I'm thinking this run will go higher than .22 eventually, keeping in mind that it took 3 months from the beginning of the last move until its peak.
MJNA trade ideas
MJNA is going to go through the roof IMO 😳OMG, this is finally happening folks. The house passed the marijuana banking bill, and the senate is now dem controlled. The act passed with 76% approval in the House. If the Senate can get the same level of support, this bill will pass whether the president wants it to or not. Who knows, the President may support this bill. I've been waiting a decade for this news. 😵
Tomorrow is the time to get on the boat. 😳
2degreez - MJNA BULLISH - Proceed with Extreme CautionI do not normally do penny stocks but I might post 1 from time to time. HIGHLY DANGEROUS - EXTREMELY CAUTIOUS - NOT FINANCIAL ADVICE
I played MJNA a few times over the the past several years and was lucky enough to rode it up to .25 back in 2013. Educational chart post only.
The Content is for informational and educational purposes only. This is not in any way, shape or form financial or trading advice.
Good luck, happy trading and stay chill,
2degreez
MEDICAL MARIJUANA SHORT (MJNA)Okay so this is uncharted territory for me. The pot-head market seems very bearish but it has gone through its fair share of market cycles. Prices might just edge a bit higher in order for them to test the upper channel resistance, but i would advise traders to open a short position at the break of the short-term bullish trendline which i drew in the descending channel.
MJNA Target 0.50 - 1.00This stock is pretty much looked at as the otc ETF for the marijuana sector.
Target based on the sector. The other targets I have mentioned are based on company financials and fundamentals
Business Description
Medical Marijuana Inc. (OTC Pink Sheets; MJNA) is the first publicly held company vested in the cannabis and industrial hemp space in America. Through its subsidiaries and investment holdings the Company focuses on the development, sale and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol ("CBD") and other products containing CBD-rich hemp oil ("Legal Hemp"). Company products are formulated for the pharmaceutical, nutraceutical and cosmeceutical industries, including dietary supplements, prescription-based hemp oil for sale in countries that have legalized our hemp oil for the treatment of various illnesses and conditions (such as Brazil and Mexico) and skin care products. The Company is not in the business of selling or dispensing either recreational or medical marijuana, directly or indirectly, so long as marijuana remains a federally controlled substance, however, we are poised and consider ourselves well-positioned for eventual cannabis legalization (the Company's products contain only those substances that are derived from the part of the cannabis plant that is excluded from the definition of marijuana under the Controlled Substances Act and are both federally legal and outside of the purview of the Drug Enforcement Administration).
Medical Marijuana, Inc. and Subsidiaries HempMeds® Mexico, HempMeds® Brazil and Kannaway® Announce 2017 as the Largest Revenue Year in Company History
PR Newswire
SAN DIEGO, Jan. 8, 2018
SAN DIEGO, Jan. 8, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company and its subsidiaries HempMeds® Mexico, HempMeds® Brazil and Kannaway® generated the largest-ever (unaudited) revenue year in its history in 2017, as well as reached major milestones in its business operations.
In 2017, Medical Marijuana, Inc. had a number of significant accomplishments, including:
Experienced year over year revenue growth of more than 300% compared to 2016
Medical Marijuana, Inc. CEO Dr. Stuart Titus spoke at several national and international cannabis conferences including A4M Mexico, the California Cannabis Business Expo, World Medical Cannabis Conference & Expo, ExpoWeed, the International Fair of Medical Cannabis and the Marijuana Business Conference & Expo
Announced the promotion of Vice President of Operations, who also serves as Kannaway CEO, Blake N. Schroeder, Esq., to Chief Operating Officer
Appointed Alex Grapov as new International Vice President, Jim Gibson as new Vice President of Operations and Stephen Jones as Chief Marketing Officer
Medical Marijuana, Inc. subsidiary Kannaway® was the first direct sales company to offer phyto-cannabinoid botanical products to consumers. A family-oriented company, Kannaway® encourages its brand ambassadors to create their own successful distribution businesses that will positively benefit the wellbeing of the people around them.
In 2017, Kannaway® had a number of significant accomplishments including:
Launched new products including a Hempy's® line of clothing products, Kannaway® Energy Chews, Kannaway® Essential Oils, updated HempVAP® Terpene-infused Vape, Kannaway® SuperGreens and Kannaway® Pure Gold
Announced international expansion with the establishment of Kannaway® Europe
Experienced year over year revenue growth of more than 500% compared to 2016
Achieved the largest sales year in its history.
HempMeds® Mexico is Medical Marijuana, Inc.'s distribution branch in the country, focusing on providing non-psychoactive cannabidiol (CBD) products to the people of Mexico. HempMeds® Mexico was the first company to have a medical cannabis product approved for import into Mexi
MJNA SESSIONS DIP BUYSessions' repeal of four Obama-era memorandums that affected RECREATIONAL scared a lot of frail investors which is a golden trade opportunity. MJNA's backbone is CBD-based, not recreational, not to mention holds other diversified holdings that will weather this nonsense idiotic political power play. Enjoy your free discount and 80% upside. Or enjoy holding this otherwise solid American company if you like its fundamentals.